Seres Therapeutics(MCRB) - 2023 Q2 - Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Carlo Tanzi - IR Officer Eric Shaff - President and CEO Lisa von Moltke - EVP and Chief Medical Officer Terri Young - Chief Commercial Officer David Arkowitz - EVP, CFO and Head of Business Development Matthew Henn - Chief Scientific Officer Conference Call Participants Joseph Thome - TD Cowen Edward Tenthoff - Piper Sandler Tessa Romero - JPMorgan Operator Ladies and gentlemen, thank you f ...